Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). aXichem AB's share price for the quarter that ended in Mar. 2026 was kr1.565. aXichem AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 67.73 Mil. Therefore, aXichem AB's market cap for the quarter that ended in Mar. 2026 was kr106.00 Mil.
aXichem AB's quarterly market cap
declined
from Sep. 2025 (kr187.39 Mil) to Dec. 2025 (kr122.37 Mil) and
declined
from Dec. 2025 (kr122.37 Mil) to Mar. 2026 (kr106.00 Mil).
aXichem AB's annual market cap
declined
from Dec. 2023 (kr86.20 Mil) to Dec. 2024 (kr80.10 Mil) but then
increased
from Dec. 2024 (kr80.10 Mil) to Dec. 2025 (kr122.37 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. aXichem AB's Enterprise Value for Today is kr175.05 Mil.
aXichem AB (OSTO:AXIC A) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
aXichem AB Market Cap Related Terms
aXichem AB Market Cap Historical Data
* Premium members only.
The historical data trend for aXichem AB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:AXIC A vs LIN, SHW, ECL: Market Cap Comparison
For the Specialty Chemicals subindustry, aXichem AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
aXichem AB Market Cap vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, aXichem AB's Market Cap distribution charts can be found below:
* The bar in red indicates where aXichem AB's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
aXichem AB's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
aXichem AB (OSTO:AXIC A) has a Market Cap of kr173.39 Mil as of Jul. 20, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on aXichem AB and its competitors. According to the industry distribution chart, aXichem AB ranks #1372 out of 1632 companies in the Chemicals industry, placing it in the top 84.1%.
Is aXichem AB's Market Cap too high?
aXichem AB's current Market Cap is kr173.39 Mil. Based on the distribution chart, aXichem AB ranks #1372 out of 1632 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, aXichem AB has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does aXichem AB's Market Cap compare to LIN and SHW?
According to the Chemicals industry distribution chart, aXichem AB ranks #1372 out of 1632 companies for Market Cap. This places aXichem AB in the lower half of its industry. The industry median Market Cap is 280.27. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Chemicals company?
The median Market Cap among Chemicals companies is 280.27, based on 1,632 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on aXichem AB and its competitors. For the Chemicals industry, the median Market Cap is 280.27 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. aXichem AB's current Market Cap is kr173.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is aXichem AB stock overvalued right now?
Based on GuruFocus' analysis, aXichem AB (OSTO:AXIC A) is currently considered Modestly Undervalued. The stock's GF Value™ is kr3.59, compared to a current price of kr2.56 — trading 28.7% below its estimated fair value. The current Market Cap is kr173.39 Mil. aXichem AB's overall GF Score™ is 65/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For aXichem AB (OSTO:AXIC A), the current Market Cap is kr173.39 Mil as of Jul. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is aXichem AB (OSTO:AXIC A) Overvalued in 2026?
Based on GuruFocus' analysis, aXichem AB stock appears to be undervalued.
The current stock price of kr2.56 is trading 28.7% below its estimated GF Value™ of kr3.59.
GuruFocus considers aXichem AB to be Modestly Undervalued.
Key valuation signals for OSTO:AXIC A:
Market Cap: kr173.39 Mil
GF Value™: kr3.59 vs. price of kr2.56 (28.7% below fair value)
No single metric tells the full story. See the OSTO:AXIC A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
aXichem AB develops, patents, markets and sells natural analogue industrial chemicals, which are synthetically produced substances with similar and comparable properties to natural substances. The Company's business concept is to develop, patent, market and sell natural analogue industrial chemicals. Its commercial focus is on the proprietary patented product phenylcapsaicin, the Company's first product, which is marketed under the registered trademarks aXiphen as an additive in animal feed and aXivite as an ingredient in food supplements and as a bioenhancer. The Company's product portfolio comprises Phenylcapsaicin, aXiphen, aXiphen bio, and aXivite. The Company's focus is on establishing aXiphen as an additive in poultry feed and pig feed.
65GF Score
Get the complete analysis for OSTO:AXIC A
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:AXIC A has been successfully added to your 
